Taken together, the authors suggest a potential benefit to adding GLP-1 to insulin therapy in adults with type 1 diabetes and offer different mechanisms by which GLP-1 may mediate these improvements. This evidence concerns the gene GLP1R and type 1 diabetes mellitus.